Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEFoundations — rating scales and measurement-based care

Psych CASC / OSCE · Foundations — rating scales and measurement-based care

Explain a symptom score and negotiate a treatment change — CASC communication station

MRCPsych/FRANZCP-style CASC: explain MBC, interpret PHQ-9/GAD-7, risk screen, shared decision on optimisation, plan remeasure.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 41-year-old on sertraline 50 mg for 6 weeks completes PHQ-9 = 16 (item 9 = 0) and GAD-7 = 11. They feel 'forms are pointless.' You must explain scores without jargon, complete a brief risk check, and collaboratively propose a measurement-based treatment adjustment.

Station brief

Format. Communication station, approximately 7–10 minutes active time after reading. You are the psychiatry registrar in a community clinic. [3]

Candidate instructions. Build rapport. Explain why questionnaires are used (to track change and guide decisions). Interpret PHQ-9 16 and GAD-7 11 in plain language without claiming a laboratory diagnosis. Check suicidal thoughts even if item 9 is 0 today. Explore side effects, adherence, and goals. Propose a collaborative plan (e.g. dose optimisation within product guidance, adherence support, psychotherapy access, earlier review) and agree when to remeasure. Avoid jargon, cut-off worship, and invented legal section numbers. [1][2][3]

Candidate scenario

Your patient is 41, English-speaking, employed part-time. They started sertraline 50 mg six weeks ago after a depressive episode with prominent worry. They completed today’s questionnaires reluctantly. PHQ-9 total 16 (moderately severe band on Kroenke anchors) with item 9 = 0; GAD-7 = 11 (above common screen cut-point of 10). They say numbers feel cold. If asked about suicide they deny current plan/intent but describe passive thoughts last month. Adherence is mostly good; sexual side effects are bothersome. They want to feel better for work. [1][2]

Marking domains

  • Empathy and destigmatising explanation of MBC [3][5]
  • Accurate plain-language score interpretation (severity bands ≠ diagnosis) [1][2]
  • Suicide risk exploration beyond the form [1]
  • Shared decision: treat-to-target using measurement logic [3][4]
  • Adherence and side-effect enquiry
  • Concrete remeasure plan and safety-net
  • Professional close without checklist robotic tone
Reveal assessor key

Open. Thank them for completing forms; explain that scores help both of you see whether treatment is working, like tracking blood pressure — but feelings and story still come first. [3]

Interpret. PHQ-9 16 suggests moderately severe depressive symptoms on a widely used scale (bands 5/10/15/20), not a barcode diagnosis. GAD-7 11 means anxiety symptoms are still significant (screen cut-point often 10). Link to their work and daily function. [1][2]

Risk. Even with item 9 = 0 today, ask directly about hopelessness and suicidal thoughts given last month’s passive ideation; clarify current wish/intent/plan/protective factors; safety-net. [1]

Act. Six weeks on 50 mg with residual high scores → discuss options: optimise antidepressant dose if tolerated, address sexual side effects, reinforce adherence, add/intensify psychological therapy, earlier review — frame as treat-to-target MBC, not failure. [3][4]

Close. Agree next PHQ-9/GAD-7 timing (e.g. 2–4 weeks), crisis contacts, and collaborative summary. [5]

Common station failures

Reading cut-offs as diagnoses; skipping suicide questions because item 9 is 0; arguing with the patient about “needing forms”; no treatment change despite non-response; no remeasure plan; overloading with trial acronyms without plain language. [1][3]

References

  1. [1]Kroenke K, Spitzer RL, Williams JB The PHQ-9: validity of a brief depression severity measure J Gen Intern Med, 2001.PMID 11556941
  2. [2]Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7 Arch Intern Med, 2006.PMID 16717171
  3. [3]Fortney JC, Unützer J, Wrenn G, et al. A Tipping Point for Measurement-Based Care Psychiatr Serv, 2017.PMID 27582237
  4. [4]Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am J Psychiatry, 2006.PMID 16390886
  5. [5]Lewis CC, Boyd M, Puspitasari A, et al. Implementing Measurement-Based Care in Behavioral Health: A Review JAMA Psychiatry, 2019.PMID 30566197